DeepMed Research

Ferring Pharmaceuticals, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.ferringusa.com

Clinical Trials

Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

Completed

Conditions: Controlled Ovarian Stimulation

Interventions: Drug: Follitropin Delta

First Posted Date: 2020-08-07

Last Posted Date: 2021-12-14

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 250

Registration Number: NCT04503707

Locations: 🇫🇷
Pierre OGER, Rueil-Malmaison, France
🇫🇷
CHU Nantes Hôpital Hôtel Dieu, Nantes, France
🇫🇷
Hôpital Femme Mère Enfant, BRON cedex, France

and more 11 locations

Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea

Completed

Conditions: Ulcerative Colitis

First Posted Date: 2020-08-05

Last Posted Date: 2022-09-10

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 11385

Registration Number: NCT04499495

Locations: 🇰🇷
Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of

Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study)

Not Applicable

Completed

Conditions: Mild-to-moderate Ulcerative Colitis

Interventions: Other: PRO-2 Scoring
Other: Faecal Calprotectin Home Test

First Posted Date: 2020-04-10

Last Posted Date: 2024-05-22

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 250

Registration Number: NCT04340895

Locations: 🇮🇹
Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
🇭🇺
University of Pecs, Pécs, Hungary
🇨🇿
EGK s.r.o. - Sanatorium sv. Anny, Praha, Czechia

and more 39 locations

Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)

Completed

Conditions: Nocturia Due to Nocturnal Polyuria

Interventions: Drug: Desmopressin

First Posted Date: 2020-04-01

Last Posted Date: 2024-12-20

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 1087

Registration Number: NCT04329975

Locations: 🇯🇵
Survey Site (there may be other sites in this country), Tokyo, Japan

Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)

Phase 3

Completed

Conditions: Infertility

Interventions: Drug: MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL
Drug: MENOPUR powder and solvent for solution for injection, 75 IU
Other: Placebo (for MENOPUR powder and solvent for solution for injection)
Other: Placebo (for MENOPUR solution for injection in pre-filled pen)

First Posted Date: 2019-11-14

Last Posted Date: 2023-11-07

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 405

Registration Number: NCT04163458

Locations: 🇺🇸
OU Physicians Reproductive Medicine, Oklahoma City, Oklahoma, United States
🇺🇸
Yale Fertility Center, New Haven, Connecticut, United States
🇺🇸
Center for Reproductive Medicine, Winter Park, Florida, United States

and more 17 locations

Rekovelle PK Trial in Chinese Women

Phase 1

Completed

Conditions: Infertility

Interventions: Drug: Follitropin Delta

First Posted Date: 2019-11-05

Last Posted Date: 2023-02-14

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 24

Registration Number: NCT04150861

Locations: 🇨🇳
First Hospital Affiliated to Nanjing Medical University Jiangsu Province Hospital, Nanjing, China

A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US

Completed

Conditions: Nocturnal Polyuria

Interventions: Diagnostic Test: Testing of EpiNP baseline survey, bladder diary and a qualitative interview
Diagnostic Test: Baseline EpiNP survey
Diagnostic Test: Bladder diary
Other: No other intervention

First Posted Date: 2019-10-14

Last Posted Date: 2023-03-13

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 10190

Registration Number: NCT04125186

Locations: 🇺🇸
Evidera Inc., Seattle, Washington, United States

Study Assessing CLENPIQ As Bowel Preparation for Pediatric Colonoscopy

Phase 1

Recruiting

Conditions: Bowel Preparation

Interventions: Drug: CLENPIQ
Drug: MIRALAX

First Posted Date: 2019-10-02

Last Posted Date: 2025-02-05

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 30

Registration Number: NCT04113382

Locations: 🇺🇸
Ferring Investigational Site, Bronx, New York, United States

Cortiment® MMX Pharmacokinetic Study

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Budesonide

First Posted Date: 2019-09-06

Last Posted Date: 2019-10-21

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 24

Registration Number: NCT04080713

Locations: 🇮🇳
Lambda Therapeutic Research Ltd, Ahmedabad, Gujrat, India

Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)

Phase 3

Completed

Conditions: Infertility, Female

Interventions: Drug: FE 999049 + GnRH antagonist (CETROTIDE)
Drug: FE 999049 + GnRH agonist (GONAPEPTYL)

First Posted Date: 2019-01-18

Last Posted Date: 2024-05-13

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 437

Registration Number: NCT03809429

Locations: 🇦🇹
Das Kinderwunsch Institut Schenk GmbH, Dobl, Austria
🇳🇴
Oslo University Hospital, Oslo, Norway
🇳🇴
Sykehuset Telemark HF, Porsgrunn, Norway

and more 13 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy